Stay updated on GM T-cell Therapy in AML/BPDCN Clinical Trial
Sign up to get notified when there's something new on the GM T-cell Therapy in AML/BPDCN Clinical Trial page.

Latest updates to the GM T-cell Therapy in AML/BPDCN Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no user-visible content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedUI updates add a visible glossary toggle and display updated metadata: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; the previous metadata items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe website was updated from Revision: v3.3.3 to Revision: v3.3.4; no study details or user-facing content were modified.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a separate Locations header with California and updated the page revision to v3.3.3; the old combined California Locations entry and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check91 days agoChange DetectedDifference0.0%

Stay in the know with updates to GM T-cell Therapy in AML/BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GM T-cell Therapy in AML/BPDCN Clinical Trial page.